These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1473 related items for PubMed ID: 16181219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC.
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ.
    N Engl J Med; 1996 Jun 27; 334(26):1685-90. PubMed ID: 8637512
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G.
    CMAJ; 2003 Oct 14; 169(8):767-73. PubMed ID: 14557314
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services.
    O'Brien SF, Yi QL, Fan W, Scalia V, Fearon MA, Allain JP.
    Vox Sang; 2012 Jul 14; 103(1):83-6. PubMed ID: 22289147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
    Offergeld R, Faensen D, Ritter S, Hamouda O.
    Euro Surveill; 2005 Feb 14; 10(2):8-11. PubMed ID: 15735310
    [Abstract] [Full Text] [Related]

  • 19. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
    Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH, NHLBI-REDS NAT Study Group.
    Transfusion; 2005 Feb 14; 45(2):254-64. PubMed ID: 15660836
    [Abstract] [Full Text] [Related]

  • 20. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion Center.
    Ouattara H, Siransy-Bogui L, Fretz C, Diane KM, Konate S, Koidio A, Minga KA, Hyda J, Koffi-Abe N, Offoumou AM, Abissey S.
    Transfus Clin Biol; 2006 Oct 14; 13(4):242-5. PubMed ID: 16822686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.